Clicky

Tarsus Pharmaceuticals, Inc.(TARS) News

Date Title
Jul 29 Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
Jul 12 When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?
May 12 Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates
May 10 Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
May 9 Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
May 9 Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript
May 9 Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
May 8 Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
May 8 Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
May 6 Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?
May 1 Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Apr 23 Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
Apr 19 Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
Apr 8 Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
Apr 4 Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
Apr 1 Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
Mar 6 How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%
Mar 5 Tarsus to Participate at Upcoming Investor Conferences
Mar 5 Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
Dec 11 Tarsus Announces Positive Topline Results from the Ersa Phase 2a Clinical Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites